Desai S and Barton R |
Role of platelet activating factor in the pathogenesis of active and passive models of experimental allergic encephalomyelitis in the rat. |
1990 |
Agents Actions |
pmid:2285021
|
Howat DW et al. |
An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats. |
1989 |
Agents Actions |
pmid:2801340
|
Appleby P and Bowen JG |
Cutaneous inflammatory disorders. |
1990 |
Agents Actions |
pmid:2117335
|
Lundgren JD et al. |
Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway. |
1990 |
Agents Actions |
pmid:2117336
|
Swingle KF and Reiter MJ |
Inhibition of Paf-acether-induced edema of the rat's paw. |
1986 |
Agents Actions |
pmid:2875631
|
Flower RJ |
Background and discovery of lipocortins. |
1986 |
Agents Actions |
pmid:2938452
|
Cahill M et al. |
Effect of des arginine9-bradykinin and other bradykinin fragments on the synthesis of prostacyclin and the binding of bradykinin by vascular cells in culture. |
1988 |
Agents Actions |
pmid:3051930
|
Cunha FQ et al. |
Failure of PAF-acether to induce in vivo neutrophil migration. |
1988 |
Agents Actions |
pmid:3055873
|
Touvay C et al. |
Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. |
1986 |
Agents Actions |
pmid:3754380
|
Kusner EJ et al. |
Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat. |
1987 |
Agents Actions |
pmid:3577957
|
Northover AM |
In vitro effects of PAF on venous endothelial cell actin disposition. |
1992 |
Agents Actions |
pmid:1509977
|
Benveniste J |
Platelet-activating factor (PAF-acether): present status. |
1981 |
Agents Actions |
pmid:6176101
|
Northover AM and Northover BJ |
Lectin-induced increase in microvascular permeability to colloidal carbon in vitro may involve protein kinase C activation. |
1994 |
Agents Actions |
pmid:7942320
|
Perret BA et al. |
Binding of bovine factor VIII-coated colloidal gold particles to receptors on platelet membranes. |
1981 |
Agents Actions |
pmid:6803540
|
Lecrubier C et al. |
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. |
1983 |
Agents Actions |
pmid:6858789
|
Heller R et al. |
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells. |
1993 |
Agents Actions |
pmid:7517616
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding. |
1984 |
Agents Actions |
pmid:6532184
|
Czarnetzki BM and Benveniste J |
Effect of synthetic PAF-acether on human neutrophil function. |
1981 |
Agents Actions |
pmid:7041568
|
Camussi G et al. |
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2). |
1981 |
Agents Actions |
pmid:7041569
|
de Bernardis E et al. |
Protective effects of papaverine salicylate in mouse ear dermatitis and PAF-induced rat paw oedema. |
1994 |
Agents Actions |
pmid:7847181
|